OrbusNeich, Boston Scientific Settle Patent Litigation

            OrbusNeich, Boston Scientific Settle Patent Litigation

PR Newswire

FORT LAUDERDALE, Fla. and NATICK, Mass., Sept. 17, 2013

FORT LAUDERDALE, Fla. and NATICK, Mass., Sept. 17, 2013 /PRNewswire/ --
OrbusNeich Medical Inc. and Boston Scientific Corporation (NYSE: BSX) have
settled all stent-related litigation between the companies. The agreement
resolves cases brought by the parties in Germany, the Netherlands, Ireland,
the United Kingdom and the United States. The agreement, which includes a
one-time payment from Boston Scientific to OrbusNeich, settles all
stent-related disputes between the companies and does not include future
financial obligations.

About OrbusNeich
OrbusNeich is a global company that designs, develops, manufactures and
markets innovative medical devices for the treatment of vascular diseases.
Current products are the world's first dual therapy stent, the COMBO™ Dual
Therapy Stent, and the world's first pro-healing stent, the Genous™ Stent.
Other products include stents and balloons marketed under the names of Azule™,
R stent, Scoreflex™, Sapphire™, Sapphire II and Sapphire NC. OrbusNeich is
headquartered in Hong Kong and has operations in Shenzhen, China; Fort
Lauderdale, Fla.; Hoevelaken, The Netherlands; and Tokyo, Japan. OrbusNeich
supplies medical devices to interventional cardiologists in more than 60
countries. For more information, visit www.OrbusNeich.com.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that
improve the health of patients around the world. As a global medical
technology leader for more than 30 years, we advance science for life by
providing a broad range of high performance solutions that address unmet
patient needs and reduce the cost of healthcare. For more information, visit
www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS:                  OrbusNeich Medical:
Boston Scientific:          Jamie Moser / Bryan Darrow
                            Joele Frank, Wilkinson Brimmer Katcher
Peter Lucht                 212-355-4449
Media Relations
508-650-8796
media@bsci.com
Michael Campbell
508-650-8023
Investor Relations
investor_relations@bsci.com







SOURCE OrbusNeich Medical Inc.; Boston Scientific Corporation

Website: http://www.OrbusNeich.com
Website: http://www.bostonscientific.com
 
Press spacebar to pause and continue. Press esc to stop.